Trials / Completed
CompletedNCT01104740
Dengue Seroprevalence Study in Blood Donors in the French West Indies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 817 (actual)
- Sponsor
- Etablissement Français du Sang, Martinique · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Dengue is an infectious disease most prevalent in the world. This disease is endemic in the Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a classical form with fever, and even of severe or lethal bleeding. With the possible existence of silent forms of the disease, there are no data identifying the current level of protection of the population in Martinique / Guadeloupe.
Detailed description
1. Principal objective: To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood donors in the French West Indies. 2. Secondary objective: To specify the serotypic specificity of the anti-dengue antibodies detected during the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biological sample collection | Blood (serum) sample collection |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-05-01
- Completion
- 2012-05-01
- First posted
- 2010-04-15
- Last updated
- 2021-08-20
Locations
2 sites across 2 countries: Guadeloupe, Martinique
Source: ClinicalTrials.gov record NCT01104740. Inclusion in this directory is not an endorsement.